T1	Participants 222 249	patients with schizophrenia
T2	Participants 401 448	patient with schizophrenia receiving medication
T3	Participants 848 853	Japan
T4	Participants 1297 1489	patients with schizophrenia aged 20 years or over who required antipsychotic medication or switching of the current medication to others for reasons such as lack of efficacy and intolerability
T5	Participants 1718 1762	The target number of subjects was set at 300
T6	Participants 2022 2058	ordinary healthcare setting in Japan
